| Market Cap | ₹5,109Cr |
| ROE | 0.00% |
| P/E Ratio(TTM) | 76.11 |
| EPS(TTM) | 6.69 |
| P/B Ratio | 5.37 |
| Dividend Yield | 0.00% |
| Industry P/E | 55.86 |
| Book Value | 94.78 |
| Debt to Equity | 0.36 |
| Face Value | 2 |
| NSE Symbol | NEPHROPLUS |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | NA (0.00%) | 56.56 | ||
| Max Healthcare Institute | NA (0.00%) | 71.08 | ||
| Fortis Healthcare | NA (0.00%) | 61.31 | ||
| Narayana Hrudayalaya | NA (0.00%) | 42.28 |